UK biotech sees worst funding downturn since 2012
pharmaphorum
JANUARY 27, 2023
Indeed, Initial Public Offerings (IPOs) raised just £28 million – the worst annual haul since 2012 – and, during the entirety of last year, UK biotech raised just £1.8 There is global capital out there for us to attract, as well as finance in the City of London [that] we need to unlock, but competition is fierce.” billion in 2021.
Let's personalize your content